Contineum Therapeutics Inc (CTNM)
NASDAQ
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Quarter End | Mar 2024 |
|---|---|
| USD ($) | |
| Total Revenue | 0 |
| Operating Income | -9.93M |
| Pre Tax Income | -8.42M |
| Net Income | -8.42M |
| Preferred Dividends | 0 |
| Basic Earnings Per Share (EPS) | 0 |
| EBIT | -9.94M |
| EBITDA | -9.87M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 50M |
| Operating Income | 16.08M |
| Pre Tax Income | 23.17M |
| Net Income | 22.72M |
| Preferred Dividends | 0 |
| Basic Earnings Per Share (EPS) | 0.222 |
| EBIT | 15.9M |
| EBITDA | 16.27M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
